| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics
|
Jun 15, 2026 | BUY |
Strong Buy
+8.9% avg upside
29 analysts
|
$132.00
62.15% Upside
|
-4.4% |
|
COAG
Hemab Therapeutics Holdings, Inc.
|
Jun 08, 2026 | BUY |
Strong Buy
+42.7% avg upside
5 analysts
|
$39.00
39.11% Upside
|
· |
|
TNGX
Tango Therapeutics
|
May 14, 2026 | HOLD |
Strong Buy
+24.2% avg upside
14 analysts
|
$27.00
4.90% Downside
|
+29.8% |
|
CRBP
Corbus Pharmaceuticals
|
May 12, 2026 | BUY |
Strong Buy
+338.6% avg upside
20 analysts
|
$33.00
305.32% Upside
|
-3.5% |
|
BCYC
Bicycle Therapeutics
|
Apr 30, 2026 | BUY |
Strong Buy
+504.5% avg upside
20 analysts
|
$12.00
200.83% Upside
|
-7.6% |
|
CMPX
Compass Therapeutics
|
Apr 27, 2026 | BUY |
Strong Buy
+372.3% avg upside
19 analysts
|
$9.00
342.35% Upside
|
+1.1% |
|
ERAS
Erasca
|
Apr 13, 2026 | BUY |
Strong Buy
+38.6% avg upside
14 analysts
|
$21.00
52.63% Upside
|
-14.3% |
|
IDYA
IDEAYA Biosciences
|
Apr 05, 2026 | BUY |
Strong Buy
+55.3% avg upside
29 analysts
|
$52.00
67.72% Upside
|
-3.3% |
|
KOD
Kodiak Sciences
|
Mar 26, 2026 | BUY |
Buy
+37.6% avg upside
11 analysts
|
$56.00
57.93% Upside
|
-10.2% |
|
VALN
Valneva
|
Mar 23, 2026 | BUY |
Strong Buy
+107.9% avg upside
5 analysts
|
$15.00
179.28% Upside
|
-12.5% |
|
ENGN
enGene Holdings
|
Feb 25, 2026 | BUY |
Buy
+478.3% avg upside
13 analysts
|
$28.00
1527.87% Upside
|
-82.7% |
|
RZLT
Rezolute
|
Dec 08, 2025 | BUY |
Strong Buy
+122.3% avg upside
13 analysts
|
$20.00
293.40% Upside
|
-67.2% |
|
AUPH
Aurinia Pharmaceuticals
|
Nov 07, 2025 | BUY |
Strong Buy
-7.1% avg upside
12 analysts
|
$21.00
28.51% Upside
|
+12.7% |
|
OPK
Opko Health
|
Oct 31, 2025 | HOLD |
Strong Buy
+374.3% avg upside
12 analysts
|
$1.60
12.20% Upside
|
-16.9% |
|
ALNY
Alnylam Pharma
|
Oct 30, 2025 | BUY |
Strong Buy
+23.4% avg upside
51 analysts
|
$549.00
98.27% Upside
|
-37.1% |
|
BCRX
BioCryst
|
Oct 14, 2025 | BUY |
Strong Buy
+103.2% avg upside
24 analysts
|
$15.00
64.03% Upside
|
+31.3% |
|
BEAM
Beam Therapeutics
|
Oct 09, 2025 | BUY |
Strong Buy
+51.4% avg upside
25 analysts
|
$41.00
22.10% Upside
|
+5.5% |
|
TVTX
Travere Therapeutics
|
Sep 10, 2025 | BUY |
Strong Buy
-15.9% avg upside
22 analysts
|
$35.00
35.72% Downside
|
+90.5% |
|
CELC
Celcuity
|
Aug 15, 2025 | BUY |
Strong Buy
+40.6% avg upside
16 analysts
|
$79.00
9.68% Downside
|
+70.0% |
|
ORIC
Oric Pharmaceuticals
|
Aug 13, 2025 | BUY |
Strong Buy
+180.1% avg upside
19 analysts
|
$23.00
167.29% Upside
|
-15.9% |
|
CRDF
Cardiff Oncology
|
Jun 24, 2025 | HOLD |
Strong Buy
+736.8% avg upside
18 analysts
|
$3.50
188.04% Upside
|
-48.1% |
|
TSHA
Taysha Gene Therapies
|
Jun 11, 2025 | BUY |
Strong Buy
+103.3% avg upside
21 analysts
|
$8.00
26.31% Upside
|
+109.0% |
|
PRME
Prime Medicine, Inc.
|
May 19, 2025 | BUY |
Strong Buy
+210.0% avg upside
16 analysts
|
$9.00
182.55% Upside
|
+102.2% |
|
SLDB
Solid Biosciences
|
May 16, 2025 | BUY |
Strong Buy
+92.3% avg upside
23 analysts
|
$15.00
90.90% Upside
|
+149.8% |
|
SGMO
Sangamo Therapeutics
|
May 13, 2025 | BUY |
Buy
+5843.7% avg upside
16 analysts
|
$1.50
753.17% Upside
|
-69.6% |
|
MREO
Mereo Biopharma Group Plc
|
Dec 06, 2024 | BUY |
Strong Buy
+1146.9% avg upside
11 analysts
|
$7.00
2118.35% Upside
|
-45.4% |
|
MGX
Metagenomi, Inc.
|
Nov 13, 2024 | BUY |
Strong Buy
+729.0% avg upside
7 analysts
|
$21.00
1628.41% Upside
|
-19.4% |
|
TYRA
Tyra Bioscience
|
Oct 17, 2024 | BUY |
Strong Buy
+57.9% avg upside
17 analysts
|
$31.00
9.82% Upside
|
-44.2% |
|
RARE
Ultragenyx Pharmaceutical
|
Oct 04, 2024 | BUY |
Strong Buy
+142.0% avg upside
36 analysts
|
$129.00
363.18% Upside
|
-42.0% |
|
AFMDQ
Affimed
|
Apr 04, 2024 | BUY |
Buy
+12648900.0% avg upside
15 analysts
|
$20.00
19999899.94% Upside
|
· |
|
CUE
Cue Biopharma
|
Mar 13, 2024 | BUY |
Strong Buy
-66.0% avg upside
9 analysts
|
$6.00
77.95% Downside
|
-54.7% |
|
TPST
Tempest Therapeutics
|
Feb 08, 2024 | BUY |
Buy
+1662.1% avg upside
18 analysts
|
$15.00
1114.54% Upside
|
-78.9% |
|
VERA
Vera Therapeutics
|
Nov 09, 2023 | BUY |
Strong Buy
+91.0% avg upside
19 analysts
|
$26.00
26.71% Downside
|
+317.8% |
|
ARWR
Arrowhead Pharmaceuticals
|
Nov 29, 2022 | BUY |
Strong Buy
-19.1% avg upside
26 analysts
|
$75.00
7.78% Downside
|
-3.4% |
|
CRSP
Crispr Therapeutics AG
|
Sep 29, 2022 | BUY |
Buy
+39.7% avg upside
41 analysts
|
$159.00
197.40% Upside
|
-29.6% |
|
BYSI
Beyondspring
|
Dec 01, 2021 | HOLD |
Hold
+400.8% avg upside
8 analysts
|
$5.00
210.55% Upside
|
-88.4% |
|
NTLA
Intellia Therapeutics
|
Jun 22, 2021 | BUY |
Buy
+153.7% avg upside
37 analysts
|
$109.00
600.92% Upside
|
-42.3% |
|
ATRA
Atara Biotherapeutics
|
Dec 21, 2020 | HOLD |
Buy
+79.8% avg upside
18 analysts
|
$25.00
150.31% Upside
|
-30.8% |
|
ZLAB
Zai Lab
|
Jul 29, 2020 | BUY |
Strong Buy
+223.0% avg upside
13 analysts
|
$86.00
365.32% Upside
|
+81.4% |
|
KPTI
Karyopharm Therapeutics
|
Jun 23, 2020 | BUY |
Strong Buy
+146.1% avg upside
18 analysts
|
$35.00
287.26% Upside
|
-47.5% |
|
DTIL
Precision BioSciences
|
May 18, 2020 | BUY |
Strong Buy
+250.1% avg upside
12 analysts
|
$25.00
279.34% Upside
|
+30.1% |
|
BDTX
Black Diamond Therapeutics
|
Feb 24, 2020 | BUY |
Strong Buy
+987.8% avg upside
12 analysts
|
$47.00
2765.85% Upside
|
-14.2% |
|
XENE
Xenon
|
Aug 10, 2018 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$16.00
70.07% Downside
|
· |
|
ABEO
Abeona Therapeutics
|
May 22, 2018 | BUY |
Strong Buy
+196.6% avg upside
17 analysts
|
$28.00
391.23% Upside
|
-57.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.